Navigation Links
ChoiceSpine™ Granted FDA Clearance for Two New Cervical Spinal Fusion Devices
Date:5/14/2019

ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, was granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market TIGER SHARK C interbody device with BioBond™ technology and BOOMERANG Anterior Cervical Plate (ACP) with a two-screw configuration, for use together or separately in cervical spinal fusion procedures.

“BOOMERANG is a versatile system of implants and instrumentation designed to simplify and improve the efficiency of anterior cervical spinal fusion procedures,“ remarked KC Gilbert, Vice President, Marketing & Education, ChoiceSpine. “The instrumentation also allows spine surgeons to simultaneously insert the BOOMERANG plate with our cervical interbody devices, such as TIGER SHARK C or STEALTH™, mimicking a stand-alone ACDF concept, eliminating surgical steps and reducing time in the operating room.”

BOOMERANG ACP features a streamlined, two-screw configuration and a single-step screw blocking mechanism for fast insertion and fixation to the anterior cervical spine. The low-profile, offset design allows for stackability at adjacent levels and enhances visual confirmation of the cervical graft in the disc space. The System’s streamlined instrumentation facilitates a simplified surgical approach while providing excellent control during the procedure.

TIGER SHARK C is a 3D manufactured, titanium alloy, cervical interbody device created with the trademarked BioBond technology. BioBond is an organic, porous interbody architecture designed for continuous porosity with an osteoconductive, hydrophilic surface. TIGER SHARK C is available in an assortment of heights with 6° of lordosis to accommodate different cervical anatomical requirements.

“We are extremely proud of our team at ChoiceSpine for successfully achieving these two FDA clearances,” said Marty Altshuler and Rick Henson, co-presidents of ChoiceSpine. “TIGER SHARK C and BOOMERANG ACP represent the ChoiceSpine commitment to providing our surgeon customers with innovative, surgeon-focused systems designed to deliver the best clinical outcomes for their spinal surgery patients.”

About ChoiceSpine
ChoiceSpine is a spinal device company located in Knoxville, TN and is privately-held by Altus Capital Partners. The Company prides itself on providing innovative, solutions-based products and exceptional service to meet the needs of their customers. ChoiceSpine offers a breadth of surgeon-focused systems that are designed to be safe, efficient, and easy-to-use. By working closely with physicians and maintaining a service-focused distribution network, ChoiceSpine will continue to bring technically-superior spinal products to market.

About Altus Capital Partners
Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing provides us with a unique understanding of the opportunities and challenges faced by companies in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. With offices in Wilton, CT and Lincolnshire, IL, Altus Capital Partners has completed 18 platform investments and numerous add on acquisitions since 2003. For more information, please visit http://www.altuscapitalpartners.com.

Read the full story at https://www.prweb.com/releases/choicespine_granted_fda_clearance_for_two_new_cervical_spinal_fusion_devices/prweb16309251.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Natreon is Granted a U.S. Patent on its CROMINEX® Product
2. OtiTopic Granted Two Patents Covering its Dry Powder Inhaled Aspirin for the Treatment of Suspected Myocardial Infarction
3. Viora Granted New Patent for SVC Technology to Enhance Patient Experience and Ease of Application for Fractional Radiofrequency (RF) Treatments
4. FDA Clearance Granted to QT Ultrasound® for New Breast Imaging Device
5. Clinical Trial Treatment Offered at Sanford Granted FDA Approval
6. HealthyYOU Vending Granted Stipulated Judgment and Permanent Injunction Against Chris Wyland and Grow Healthy Vending in Lawsuit Settlement
7. Spinal Simplicity Announces Six New Patents Granted in 2016
8. Family Centered Treatment (FCT) Foundation Granted Continuing Education Provider Status
9. Mississippi Native Gets Wish Granted to See Atlanta Hawks Basketball Game
10. Vasont Systems Granted ISO 9001:2008 Certification for Quality Management
11. California Southern University Nursing Programs Granted Final Approval by WASC Senior College and University Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2019)... ... July 12, 2019 , ... cbdMD, Inc., a nationally recognized ... Watch” by Brightfield Group, a leading cannabis research firm. In their recent mid-year ... CBD companies in two categories, Topicals and Skincare/Beauty. , "There is a massive ...
(Date:7/11/2019)... ... July 11, 2019 , ... Swagelok Southeast ... of its territory through the acquisition of another Houston-area distributor. The acquisition of ... three facilities located in LaPorte, Nederland and Houston. , With this expansion, ...
(Date:7/10/2019)... , ... July 10, 2019 , ... HMP, a leader ... official partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in ... of Clinical Pathways and focuses on the expansion of clinical pathways as a decision ...
(Date:7/9/2019)... , ... July 09, 2019 , ... Human cytomegalovirus (HCMV) ... Xiaoping Zhu, professor and chair in Veterinary Medicine at UMD, half of the population ... in your body for the rest of your life and can flare up whenever ...
(Date:7/9/2019)... (PRWEB) , ... July 09, 2019 , ... ... organizations (DSO) providing business support services to more than 400 affiliated offices across ... in Round Rock, Texas. , Smile Brands will provide full-service administrative support to ...
Breaking Medicine News(10 mins):
(Date:7/13/2019)... ... July 12, 2019 , ... ... communicate and socialize with others. Given how widespread autism is (approximately 1 in ... While autism cannot be “cured,” there are treatment options to teach children with ...
(Date:7/11/2019)... ... 11, 2019 , ... Voted one of “The Most ... a luminary of the cosmetic world to “represent a revolutionary scientific breakthrough in ... derived from exotic conifer seeds. DELTA-5 technology works to reduce pro-inflammatory eicosanoid molecules ...
(Date:7/11/2019)... ... July 11, 2019 , ... Healthy Hemp Oil, a company ... TSA guidelines for domestic airline flights. , Previously, all forms of marijuana ... to allow some forms of cannabinoid (CBD) oil and FDA-approved marijuana-based ...
Breaking Medicine Technology: